Prevenar 13 Gains First Approval

Wyeth received approval from the Chilean Ministry of Health, MINSAL (Ministerio de Salud), for Prevenar 13 Valent.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wyeth received approval from the Chilean Ministry of Health, MINSAL (Ministerio de Salud), for Prevenar 13 Valent, (Pneumococcal Conjugate Vaccine 13 Valent (Diphtheria CRM(197) Protein)) for infants and young children. MINSAL is the first government agency to approve the vaccine. The vaccine is approved for active immunization of children aged 6 weeks through 5 years for the prevention of invasive pneumococcal disease, as well as pneumonia and otitis media (middle ear infection) caused by 1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters